Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Elisea Avalos"'
Autor:
Elisea Avalos, Donald Catanzaro, Antonino Catanzaro, Theodore Ganiats, Stephanie Brodine, John Alcaraz, Timothy Rodwell
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0120470 (2015)
The detection of mutations in the gyrA and gyrB genes in the Mycobacterium tuberculosis genome that have been demonstrated to confer phenotypic resistance to fluoroquinolones is the most promising technology for rapid diagnosis of fluoroquinolone res
Externí odkaz:
https://doaj.org/article/d1489da66aec4006a618b291cbabc9d1
Autor:
W. Cliff Rutter, Elisea Avalos-Reyes, Will Cavers, Shivaani Prakash, Kjel Johnson, Leon Bernal-Mizrachi
Publikováno v:
Blood. 140:10065-10067
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c77c9ba22b807383436dde426dd5994
https://doi.org/10.1182/blood-2022-160228
https://doi.org/10.1182/blood-2022-160228
Autor:
Sarah, McLarty, Kjel A, Johnson, E Ann, Francis, Melissa, Johlie, Christine, Sawicki, Elisea, Avalos-Reyes
Publikováno v:
The American journal of managed care. 28(7)
To assess provider and patient preferences for an oncologist selection tool, value-based care, involvement in cancer care, and end-of-life planning.We conducted a cross-sectional survey of primary care providers (PCPs) and insured patients with cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::72f3ae6f5436ff741cc4b42aca1a09c5
https://pubmed.ncbi.nlm.nih.gov/35852880
https://pubmed.ncbi.nlm.nih.gov/35852880
Autor:
Fares Awa, Peter Guasti Jr, Anoop Gurram, Olivia Sawicki, Elisea Avalos-Reyes, Ronald Aubert, Kathryn Johnson
UNSTRUCTURED As future health care providers and leaders, we provide a unique perspective on the future direction of health care in the United States. We identified several opportunities for growth in a post-pandemic future, from leveraging technolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d007d294c0c1c776895e17ea0246e09c
https://doi.org/10.2196/preprints.39691
https://doi.org/10.2196/preprints.39691
Autor:
Elias Pittos, Dipti Shah, Kelly McAuliff, Amanda McCarthy, William Cavers, Rashmi Grover, Lucia Feczko, Elisea Avalos-Reyes, Kjel Andrew Johnson
Publikováno v:
Journal of Clinical Oncology. 40:123-123
123 Background: COVID-19 has impacted several areas of oncology patient care, most notably the reduction of patient visits for treatments. Standard treatment of multiple myeloma (MM) involves a combination of intravenous (IV) and oral therapies. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e978425599feb90f8e7ccbcf3e2be0c
https://doi.org/10.1200/jco.2022.40.28_suppl.123
https://doi.org/10.1200/jco.2022.40.28_suppl.123
Autor:
Wilbur Rutter, Shivaani Prakash, William Cavers, Elisea Avalos-Reyes, Kjel Andrew Johnson, Leon Bernal-Mizrachi
Publikováno v:
Journal of Clinical Oncology. 40:8023-8023
8023 Background: The introduction of novel oral immunomodulatory drugs has improved the overall survival rates of patients with multiple myeloma (MM). Poor adherence to oral therapies may lead to drug resistance, poor response to treatment and other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f5068372e96c887654b98042b436b54
https://doi.org/10.1200/jco.2022.40.16_suppl.8023
https://doi.org/10.1200/jco.2022.40.16_suppl.8023
Autor:
Elias Pittos, Wilbur Rutter, William Cavers, Dipti Shah, Kelly McAuliff, Lucia Feczko, Rashmi Grover, Elisea Avalos-Reyes, Kjel Andrew Johnson
Publikováno v:
Journal of Clinical Oncology. 40:1570-1570
1570 Background: COVID-19 has substantially decreased cancer screening, management visits and surgeries. CVS Health recently developed a best-in-class mobile app and website that enables oncology patients to start and stay on therapy. This study exam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3cdf9829ce11387a245793b66d215fa
https://doi.org/10.1200/jco.2022.40.16_suppl.1570
https://doi.org/10.1200/jco.2022.40.16_suppl.1570
Autor:
Christopher Junk, Prem R. Warde, Shanna Hoversten, Ujwal Sapkota, William Cavers, Elisea Avalos-Reyes, Kjel Andrew Johnson
Publikováno v:
Journal of Clinical Oncology. 40:e18832-e18832
e18832 Background: The American Cancer Society projects the total cost of cancer care to increase to approximately $246 billion by 2030, an increase of roughly 34% from 2015. Estimating the nature and extent of health care spending on cancer care is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2868971f84bbb5efca23e23ebce2fa16
https://doi.org/10.1200/jco.2022.40.16_suppl.e18832
https://doi.org/10.1200/jco.2022.40.16_suppl.e18832
Autor:
Edward Thompson, Alexa Hospodar, Sarah McLarty, Sabah Pervez, Heeseon Yeon, Kevin Hastings, Robert Cullum, Christopher Junk, Ujwal Sapkota, Allendre Mcgovern-Siembab, Lady Perez, Patricia Angelica, Namrata Jeshang, William Cavers, Melissa Johlie, Shirisha Reddy, Rogelio A. Brito, Elisea Avalos-Reyes, Kjel Andrew Johnson, Tracy Grunsfeld
Publikováno v:
Journal of Clinical Oncology. 40:1536-1536
1536 Background: In response to rising healthcare costs, several innovative payment strategies have emerged to improve the value and efficiency of healthcare spending. One of these strategies is a shift from volume-based to value-based care (VBC), re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a15986378591ff7ee3643b7b763ee2c
https://doi.org/10.1200/jco.2022.40.16_suppl.1536
https://doi.org/10.1200/jco.2022.40.16_suppl.1536
Publikováno v:
Journal of Clinical Oncology. 40:3624-3624
3624 Background: National Comprehensive Cancer Network (NCCN) colon cancer treatment guidelines have been developed to standardize and improve quality of care. While studies have shown that concordance to these guidelines improves survival, little in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bdd47ca6d42152fc5955e3d54d73f83
https://doi.org/10.1200/jco.2022.40.16_suppl.3624
https://doi.org/10.1200/jco.2022.40.16_suppl.3624